5 Key Facts: El Glucagon Es Una Hormona in Peptide Products
Published: July 18, 2026 16:30
Author: Sarah Rodriguez
Abstract: Glucagon, a 29-amino acid peptide hormone, is critical in glucose homeostasis and emerging in peptide therapeutics. This analysis reviews 5 key facts: its mechanism in peptide products, market trends (projected CAGR of 8.5% through 2030), and brand comparisons (e.g., Novo Nordisk vs. generic suppliers). Technical advantages include rapid action; drawbacks involve instability. Product parameters (purity >98%, endotoxin <0.5 EU/mg) and certifications (GMP, ISO 9001) are compared. Applications span diabetes, hypoglycemia, and weight management. Industry insights highlight factory audits, logistics (cold chain), and selection criteria for quality peptide products.